Ainos, Inc. AIMD
Inc. (the "Company"), incorporated in the State of Texas in 1984, is a dual-platform company advancing artificial intelligence–based
smelltech technologies and immune therapeutics. Our primary strategic focus is the commercialization of our proprietary scent digitization
platform, AI Nose, while we also continue to develop therapeutic assets based on our low-dose oral interferon program, VELDONA®.
core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $124.2K | $20.7K | $122.1K | $3.5M | $594.6K | $16.6K | $11.7K | $77.7K | $250.9K | — |
| Cost of revenue | $21.2K | $52.6K | $375.8K | $2.1M | $184.2K | $11.3K | $8.8K | $64.9K | $60.3K | — |
| Gross profit | $102.9K | -$31.9K | -$253.7K | $1.4M | $410.4K | $5.3K | $3.0K | $12.8K | $190.6K | — |
| R&D | $7.7M | $8.4M | $7.3M | $6.8M | $1.9M | $389 | $52.5K | $32.6K | — | — |
| SG&A | $6.3M | $5.4M | $5.6M | $8.5M | $2.4M | $1.4M | $1.5M | $1.3M | $770.4K | $667.1K |
| Total operating expenses | $14.1M | $13.8M | $13.0M | $15.4M | $4.3M | $1.4M | $1.6M | $1.3M | $770.4K | — |
| Operating income | -$14.0M | -$13.8M | -$13.2M | -$14.0M | -$3.9M | -$1.4M | -$1.6M | -$1.3M | -$579.8K | -$667.1K |
| Interest expense | $711.9K | $616.5K | $144.2K | $53.5K | $18.7K | $10.7K | — | $4.0K | $37.6K | $2.9K |
| Pre-tax income | -$14.8M | -$14.9M | -$13.8M | -$14.0M | -$21.2K | -$10.2K | -$1.6M | — | — | -$670.0K |
| Income tax | $800 | $800 | $800 | $0 | — | $0 | $0 | — | — | $0 |
| Net income | -$14.8M | -$14.9M | -$13.8M | -$14.0M | -$3.9M | -$1.5M | -$1.6M | -$1.3M | -$617.4K | -$670.0K |
| EPS, basic | -3.46 | -7.82 | -3.36 | — | — | — | — | — | — | — |
| EPS, diluted | -3.46 | -7.82 | -3.36 | — | -0.03 | -0.04 | -0.04 | -0.04 | -0.03 | -0.03 |
| Shares, diluted (wtd. avg.) | $4.3M | $1.9M | $4.1M | — | — | — | — | — | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $417.4K | $3.9M | $1.9M | $1.9M | $1.8M | $22.2K | $409.0K | $1.3M | $2.0M | $134.1K |
| Receivables | $22 | $56 | $455 | $201.5K | $0 | — | — | — | — | — |
| Inventory | $295.6K | $143.8K | $167.6K | $595.2K | $0 | $0 | $4.1K | — | $22.7K | $14.7K |
| Total current assets | $1.1M | $4.3M | $2.5M | $2.8M | $2.2M | $76.4K | $445.3K | $1.3M | $2.1M | $262.4K |
| Property, plant and equipment | $343.3K | $559.6K | $876.6K | $1.4M | $1.2M | $3.2K | $5.1K | $14.0K | $27.0K | $44.2K |
| Other intangibles | $19.2M | $23.7M | $28.3M | $32.8M | $37.3M | $180.6K | $146.3K | $146.5K | $182.4K | $156.1K |
| Total assets | $20.9M | $28.8M | $31.8M | $37.1M | $40.8M | $260.3K | $596.6K | $1.5M | $2.3M | $462.7K |
| Accounts payable | — | — | — | — | — | $145.6K | $208.7K | $115.3K | $159.3K | $168.8K |
| Total current liabilities | $1.1M | $4.0M | $1.3M | $2.5M | $30.6M | $1.1M | $753.3K | $733.6K | $1.8M | $1.3M |
| Total liabilities | $13.3M | $13.3M | $7.4M | $2.5M | $30.6M | $1.1M | $753.3K | $733.6K | $1.8M | $1.3M |
| Retained earnings | -$67.5M | -$52.7M | -$37.9M | -$24.1M | -$10.1M | -$6.2M | -$4.8M | -$3.2M | -$1.9M | -$1.3M |
| Total equity | $7.6M | $15.5M | $24.4M | $34.6M | $10.2M | -$838.3K | -$156.7K | $730.1K | $470.8K | -$809.9K |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$4.6M | -$5.8M | -$4.7M | -$3.0M | -$1.2M | -$499.6K | -$909.5K | -$1.0M | -$484.6K | -$520.8K |
| Depreciation and amortisation | $243.0K | $252.5K | $328.9K | $291.7K | $31.4K | $1.8K | $10.6K | $17.9K | $17.2K | $9.3K |
| Stock-based compensation | $1.7M | $3.5M | $1.1M | $6.4M | -$10.7K | $150.4K | $0 | $100.4K | $106.2K | — |
| Capital expenditure | $34.6K | $21.3K | $93.0K | $633.8K | $143.8K | $0 | $1.6K | $4.9K | — | $47.7K |
| Investing cash flow | -$2.2K | -$125.3K | -$101.5K | -$630.2K | -$180.5K | -$7.2K | -$13.1K | -$7.3K | -$49.1K | -$148.3K |
| Financing cash flow | $1.0M | $8.0M | $4.9M | $3.9M | $3.2M | $120.0K | $55.0K | $255.0K | $2.4M | $782.1K |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-013579.
Others in SIC 3577
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| PANW | Palo Alto Networks Inc | $271.61B | 208.3x | 14.9% |
| FTNT | Fortinet, Inc. | $114.67B | 64.6x | 14.2% |
| LOGI | LOGITECH INTERNATIONAL S.A. | $14.61B | 21.3x | 6.3% |
| CRSR | Corsair Gaming, Inc. | $1.38B | — | 11.9% |
| EVLV | Evolv Technologies Holdings, Inc. | $905.6M | — | 40.5% |
| MITK | MITEK SYSTEMS INC | $837.9M | 97.7x | 4.4% |
| XRX | Xerox Holdings Corp | $436.0M | — | 12.9% |
| IMMR | IMMERSION CORP | $255.9M | 55.1x | 11.2% |